BD Announces 2011 Analyst Day and Webcast

News provided by

Oct 28, 2011, 08:00 ET

FRANKLIN LAKES, N.J., Oct. 28, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will host an institutional investor and analyst meeting on Wednesday, November 9, 2011, in New York City from 7:45 a.m. – 12:45 p.m. (ET). The meeting will update the investment community on BD's corporate strategy, focusing on investing and innovating for growth.

Live webcasts of the 90-minute General Session at 7:45 a.m. and the 30-minute Q & A Session at 12:15 p.m. will be accessible through BD's website at www.bd.com/investors. A replay of the webcasts will be available through Wednesday, November 16, 2011.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:

Monique N. Dolecki, Investor Relations – 201-847-5378
Colleen T. White, Corporate Communications – 201-847-5369

SOURCE BD (Becton, Dickinson and Company)